Meyler's Side Effects of Drugs

Enteral nutrition

See also : Parenteral nutrition General information Enteral nutrition refers to any method of feeding that involves instillation of food into the gastrointestinal tract, such as normal feeding, feeding by nasogastric or nasoenteric tube, or feeding into a gastrostomy or…

Entecavir

General information Entecavir is used in treatment-naïve hepatitis B e antigen positive patients and those with evidence of lamivudine resistance. Drug studies Comparative studies In a comparison of entecavir and lamivudine, diminution of viral titers reached 7 log 10 units…

Entacapone

General information Entacapone is an inhibitor of catechol-O-methyltransferase, which catalyses a relatively minor pathway of dopamine metabolism. It therefore enhances the action of dopamine. The safety of entacapone has been specifically addressed in a Finnish study in 326 patients (mean…

Enprostil

See also Prostaglandins General information Enprostil is a synthetic analogue of PGE 2 , which has been used to treat peptic ulceration [ ]. You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles…

Enprofylline

You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here

Enoximone

See also Phosphodiesterase type III inhibitors General information Enoximone is an inhibitor of phosphodiesterase type III, and has a positive inotropic effect. Its most common adverse effects are gastrointestinal and cardiac. The gastrointestinal effects include anorexia, nausea, vomiting, and diarrhea…

Enfuvirtide

General information Enfuvirtide is a 36 amino acid synthetic peptide used for managing HIV treatment-experienced patients. It is a fusion inhibitor that binds to HR 1, blocking a conformational change on gp41 required for the fusion of the lipid envelope…

Enflurane

General information Enflurane is a non-explosive halogenated volatile anesthetic that was first marketed in 1966. It was developed in the search for agents safer than halothane and methoxyflurane [ ]. However, the list of its halothane-like adverse effects has continued…

Encainide

General information Encainide is a class I antidysrhythmic drug. Reviews of its clinical pharmacology, clinical use, efficacy, and adverse effects have appeared [ ]. Organs and systems Cardiovascular In the wake of the preliminary and final reports of the Cardiac…